Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer
Study Information
Alliance Study ID: CALGB-80402
NCT Study ID (ClinicalTrials.gov): NCT00311610
Alliance Committee: Gastrointestinal Cancer
Disease or Cancer Type: Colorectal / Colon / Rectal Cancer
Alliance Study Chair: Allyson Ocean, MD
Status: COMPLETED
Study Description
RATIONALE: Drugs used in chemotherapy, such as liposomal SN-38, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.
PURPOSE: This phase II trial is studying how well liposomal SN-38 works in treating patients with metastatic colorectal cancer.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information